Chemotherapy for relapsed epithelial ovarian cancer

Ivan Solà, Marta Roquéi Figuls, Arturo J. Martí-Carvajal, Belen Ojeda, Xavier Bonfill Cosp

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Abstract

© 2013 The Cochrane Collaboration. This is the protocol for a review and there is no abstract. The objectives are as follows: We will assess the clinical effectiveness and safety of second-line chemotherapy for treating women with ovarian cancer sensitive or resistant to a previous course of platinum-based chemotherapy.
Original languageEnglish
Article numberCD008551
JournalCochrane Database of Systematic Reviews
Volume2013
Issue number11
DOIs
Publication statusPublished - 21 Nov 2013

Fingerprint Dive into the research topics of 'Chemotherapy for relapsed epithelial ovarian cancer'. Together they form a unique fingerprint.

  • Cite this

    Solà, I., Roquéi Figuls, M., Martí-Carvajal, A. J., Ojeda, B., & Bonfill Cosp, X. (2013). Chemotherapy for relapsed epithelial ovarian cancer. Cochrane Database of Systematic Reviews, 2013(11), [CD008551]. https://doi.org/10.1002/14651858.CD008551.pub2